progression

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Star Teen Filipino Race Driver Bianca Bustamante Unveils NFT Project to Achieve her F1 Dream

Launches groundbreaking project, "The Dark Horse" NFT Access Pass, to support basic living and training costsInclusive community offers fans unprecedented insight into her journey up the global racing ladderHer NFT Access Pass includes behind-the-scenes content; additional drops and airdrops; plus future prize pools planned MANILA, May 12, 2022 - (ACN Newswire) - Bianca Bustamante, a 17 year-old rising motorsport star from the Philippines, announced that she is launching a groundbreaking project, The Dark Horse - an NFT Access Pass that redefines the career progression of young athletes by embracing technology,